The Thanyapura Sports and Health Resort in Phuket
has partnered with StemCells21 (SC21), a medical biotech company
based in Bangkok, Thailand.
As part of the dela, Thanyapura in
partnership with SC21, will offer stem cell treatments for
various degenerative diseases, immune disorders, injuries and
SC21 specialises in stem cell treatments with Mesenchymal Stem Cells (MSCs) and Induced Pluripotent Stem Cells (iPSCs).
Treatments can also tackle a host of medical
problems such as type 2 diabetes, osteoarthritis, chronic back
pain and inflammatory lung diseases such as asthma and bronchitis,
as well as strengthen body immunity and improve fertility.
Philipp Graf von Hardenberg, President & CEO of
Thanyapura World, said, “We are
excited to be working with SC21 to facilitate their first clinic
outside of Bangkok and deliver world-class treatment to guests and
members at Thanyapura. This partnership really supports in putting
us on the global stage as a leading lifestyle optimisation
destination in the sports and lifestyle industry.”
Guests can book a free dedicated one-on-one
consultation with a certified stem cell specialist for their first
Treatment packages can be customised from the
number of Premium Grade (P1) MSCs to the treatment duration and
include supportive therapies from a comprehensive health check-up
to after-care service.
“Stem cell therapy is a tool to optimise the human
body to perform at a higher level, and we want to make the
environment of the body less hazardous and more harmonious for
repair and regeneration,” said Paul Collier, Founder and Managing
Partner of SC21. “SC21 was founded to provide treatments that few
people know are available, and to offer health outcomes that are
superior to what most thought possible, and we are looking forward
to bringing our experience and expertise to Thanyapura.”